China gives conditional approval for Pfizer COVID pill Paxlovid | Coronavirus pandemic News

China’s National Medical Products Administration says more research on the drug needs to be undertaken.

China says it has given “conditional” approval for Pfizer’s COVID-19 drug Paxlovid to treat adults with mild to moderate illness and a high risk of developing severe disease.

The drug has so far been authorised in about 40 countries, while the European Union has permitted member…

Continue Reading

News Source:

Leave a comment